US Stock MarketDetailed Quotes

OKYO OKYO Pharma

Watchlist
  • 1.363
  • -0.203-12.94%
Close May 2 16:00 ET
  • 1.450
  • +0.088+6.42%
Post 20:01 ET
46.24MMarket Cap-3.59P/E (TTM)

OKYO Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
(FY)Mar 31, 2016
(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
91.85%-650.88K
-131.16%-7.98M
Net income from continuing operations
-26.49%-16.8M
-113.65%-13.28M
-84.03%-6.22M
-108.50%-3.38M
66.95%-1.62M
82.66%-4.9M
-11,584.05%-28.27M
70.50%-241.93K
90.06%-820.17K
40.72%-8.26M
Operating gains losses
38.64%53.76K
235.79%38.78K
-1,036.41%-28.56K
-118.06%-2.51K
1,292.03%13.92K
-100.00%-1.17K
--26.39M
----
-127.31%-26.9K
77.71%98.48K
Depreciation and amortization
1.82%3.87K
62.89%3.8K
-82.22%2.33K
119.28%13.11K
2,644.97%5.98K
--217.8166
--0
----
----
----
Other non cash items
2,912.53%3.46M
86.31%114.99K
-25.64%61.72K
93.73%83.01K
-98.40%42.85K
991.02%2.69M
--246.21K
----
28.53%-12.36K
-517.57%-17.29K
Change In working capital
-32.35%2.67M
485.38%3.95M
-197.99%-1.02M
460.14%1.04M
5.50%186.53K
395.04%176.81K
108.35%35.72K
-491.19%-427.71K
246.35%109.34K
-34.37%-74.71K
-Change in receivables
--0
--0
-86.65%27.38K
267.09%205.07K
6.41%-122.73K
-165.98%-131.14K
155.03%198.76K
-584.16%-361.21K
1,536.60%74.61K
94.94%-5.19K
-Change in payables and accrued expense
-41.00%2.23M
1,616.75%3.78M
-129.66%-249.09K
171.54%839.78K
0.43%309.27K
288.88%307.95K
-145.16%-163.04K
-291.48%-66.51K
149.96%34.73K
-247.53%-69.52K
-Change in other current assets
162.50%440.26K
120.91%167.72K
---802.15K
----
----
----
----
----
----
----
Cash from discontinued investing activities
0
6.56M
Operating cash flow
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
54.08%-650.88K
58.95%-1.42M
Investing cash flow
Cash flow from continuing investing activities
0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
-1.32K
0
87.85%-335.18K
73.95%-2.76M
Capital expenditure reported
----
----
----
----
----
----
----
----
85.28%-405.59K
73.48%-2.75M
Net PPE purchase and sale
--0
-254.46%-5.92K
75.96%-1.67K
---6.94K
--0
---1.32K
--0
----
1,552.67%70.41K
97.67%-4.85K
Net other investing changes
----
----
----
91.58%-11.17K
---132.67K
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
---1.32K
--0
----
87.85%-335.18K
73.95%-2.76M
Financing cash flow
Cash flow from continuing financing activities
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
963.31K
0
-96.66%12.36K
-96.45%370.51K
Net issuance payments of debt
--0
--2M
--0
27,839.94%7.58M
---27.33K
--0
----
----
-28.53%12.36K
--17.29K
Net common stock issuance
-15.22%6.21M
--7.32M
--0
-76.78%230.02K
--990.64K
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--0
13,468.18%2.15M
--15.87K
--0
----
----
----
----
56.50%353.22K
Cash from discontinued financing activities
Financing cash flow
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
--963.31K
--0
----
----
-96.66%12.36K
-96.45%370.51K
Net cash flow
Beginning cash position
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-76.03%627.62K
-40.60%2.62M
0.23%4.41M
-29.89%4.4M
-40.36%6.27M
-33.03%10.52M
Current changes in cash
-302.32%-3.28M
148.91%1.62M
-153.42%-3.32M
1,771.58%6.21M
81.35%-371.42K
-24.85%-1.99M
-144.89%-1.59M
33.11%-651.27K
74.42%-973.71K
-5.32%-3.81M
Effect of exchange rate changes
122.88%63.5K
68.18%-277.54K
-295.89%-872.14K
2,249.98%445.22K
---20.71K
----
----
--0
30.64%-171.84K
8.21%-247.75K
End cash Position
-79.56%826.85K
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-77.70%627.56K
-24.91%2.81M
-26.93%3.75M
-20.67%5.13M
-45.32%6.47M
Free cash flow
-23.24%-9.49M
-40.80%-7.7M
-240.34%-5.47M
-33.70%-1.61M
39.63%-1.2M
-24.85%-1.99M
-144.89%-1.59M
38.38%-651.27K
74.70%-1.06M
70.38%-4.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017(FY)Mar 31, 2016(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K91.85%-650.88K-131.16%-7.98M
Net income from continuing operations -26.49%-16.8M-113.65%-13.28M-84.03%-6.22M-108.50%-3.38M66.95%-1.62M82.66%-4.9M-11,584.05%-28.27M70.50%-241.93K90.06%-820.17K40.72%-8.26M
Operating gains losses 38.64%53.76K235.79%38.78K-1,036.41%-28.56K-118.06%-2.51K1,292.03%13.92K-100.00%-1.17K--26.39M-----127.31%-26.9K77.71%98.48K
Depreciation and amortization 1.82%3.87K62.89%3.8K-82.22%2.33K119.28%13.11K2,644.97%5.98K--217.8166--0------------
Other non cash items 2,912.53%3.46M86.31%114.99K-25.64%61.72K93.73%83.01K-98.40%42.85K991.02%2.69M--246.21K----28.53%-12.36K-517.57%-17.29K
Change In working capital -32.35%2.67M485.38%3.95M-197.99%-1.02M460.14%1.04M5.50%186.53K395.04%176.81K108.35%35.72K-491.19%-427.71K246.35%109.34K-34.37%-74.71K
-Change in receivables --0--0-86.65%27.38K267.09%205.07K6.41%-122.73K-165.98%-131.14K155.03%198.76K-584.16%-361.21K1,536.60%74.61K94.94%-5.19K
-Change in payables and accrued expense -41.00%2.23M1,616.75%3.78M-129.66%-249.09K171.54%839.78K0.43%309.27K288.88%307.95K-145.16%-163.04K-291.48%-66.51K149.96%34.73K-247.53%-69.52K
-Change in other current assets 162.50%440.26K120.91%167.72K---802.15K----------------------------
Cash from discontinued investing activities 06.56M
Operating cash flow -23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K54.08%-650.88K58.95%-1.42M
Investing cash flow
Cash flow from continuing investing activities 0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K-1.32K087.85%-335.18K73.95%-2.76M
Capital expenditure reported --------------------------------85.28%-405.59K73.48%-2.75M
Net PPE purchase and sale --0-254.46%-5.92K75.96%-1.67K---6.94K--0---1.32K--0----1,552.67%70.41K97.67%-4.85K
Net other investing changes ------------91.58%-11.17K---132.67K--------------------
Cash from discontinued investing activities
Investing cash flow --0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K---1.32K--0----87.85%-335.18K73.95%-2.76M
Financing cash flow
Cash flow from continuing financing activities -33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M963.31K0-96.66%12.36K-96.45%370.51K
Net issuance payments of debt --0--2M--027,839.94%7.58M---27.33K--0---------28.53%12.36K--17.29K
Net common stock issuance -15.22%6.21M--7.32M--0-76.78%230.02K--990.64K--0----------------
Proceeds from stock option exercised by employees --0--013,468.18%2.15M--15.87K--0----------------56.50%353.22K
Cash from discontinued financing activities
Financing cash flow -33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M--963.31K--0---------96.66%12.36K-96.45%370.51K
Net cash flow
Beginning cash position 49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-76.03%627.62K-40.60%2.62M0.23%4.41M-29.89%4.4M-40.36%6.27M-33.03%10.52M
Current changes in cash -302.32%-3.28M148.91%1.62M-153.42%-3.32M1,771.58%6.21M81.35%-371.42K-24.85%-1.99M-144.89%-1.59M33.11%-651.27K74.42%-973.71K-5.32%-3.81M
Effect of exchange rate changes 122.88%63.5K68.18%-277.54K-295.89%-872.14K2,249.98%445.22K---20.71K----------030.64%-171.84K8.21%-247.75K
End cash Position -79.56%826.85K49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-77.70%627.56K-24.91%2.81M-26.93%3.75M-20.67%5.13M-45.32%6.47M
Free cash flow -23.24%-9.49M-40.80%-7.7M-240.34%-5.47M-33.70%-1.61M39.63%-1.2M-24.85%-1.99M-144.89%-1.59M38.38%-651.27K74.70%-1.06M70.38%-4.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes--------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 81.620
Sample Name
Sample Code
 11.660
Sample Name
Sample Code
 6.080
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.310
5
Enerpac Tool
EPAC
41.900
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 125.760
Sample Name
Sample Code
 597.020
Sample Name
Sample Code
 179.280
4
Oracle
ORCL
150.730
5
ASML Holding
ASML
690.330
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1893
Sample Name
Sample Code
 8.390
Sample Name
Sample Code
 10.970
4
Argo Blockchain
ARBK
0.4265
5
The9 Ltd
NCTY
12.300
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -